Cargando…
Increased Level of Phosphorylated ShcA Measured by Chemiluminescence-Linked Immunoassay Is a Predictor of Good Prognosis in Primary Breast Cancer Expressing Low Levels of Estrogen Receptor
The SH2 domain-containing adaptor protein ShcA is a proto-oncogene involved in growth factor receptor signaling. The role of phosphorylated ShcA is to link receptor tyrosine kinases with the SH2-containing adaptor protein Grb2, thus facilitating signal transduction from receptor tyrosine kinases to...
Autores principales: | Cicenas, Jonas, Küng, Willy, Eppenberger, Urs, Eppenberger-Castori, Serenella |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3827597/ https://www.ncbi.nlm.nih.gov/pubmed/24281038 http://dx.doi.org/10.3390/cancers2010153 |
Ejemplares similares
-
Increased level of phosphorylated akt measured by chemiluminescence-linked immunosorbent assay is a predictor of poor prognosis in primary breast cancer overexpressing ErbB-2
por: Cicenas, Jonas, et al.
Publicado: (2005) -
p66ShcA functions as a contextual promoter of breast cancer metastasis
por: Lewis, Kyle, et al.
Publicado: (2020) -
Ras, TrkB, and ShcA Protein Expression Patterns in Pediatric Brain Tumors
por: Prill, Monika, et al.
Publicado: (2021) -
Low E2F1 transcript levels are a strong determinant of favorable breast cancer outcome
por: Vuaroqueaux, Vincent, et al.
Publicado: (2007) -
p66ShcA potentiates the cytotoxic response of triple-negative breast cancers to PARP inhibitors
por: Cañedo, Eduardo Cepeda, et al.
Publicado: (2021)